< Back to search
Filter
1

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

for
Prostate Cancer, Prostate Adenocarcinoma,
Location: New York NY, Durham NC, Madison WI
Sponsor: Duke University

Sex: Male

Age: 18+

Code: NCT06141993

Recruiting

Pilot Study of Dose Escalation in Prostate Radiotherapy Using the MR-Linac (DESTINATION-MRL)

for
Prostate Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: Male

Age: 18+

Code: NCT06177093

Recruiting

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

for
Prostate Cancer, Biochemically Recurrent
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18+

Code: NCT05588128

Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: Stony Brook NY, Bay Shore NY, Lake Success NY,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase3, Recruiting

Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI

for
Prostate Cancer
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: Male

Age: 18+

Code: NCT04992728

Recruiting

Interested in new prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

for
High-risk Prostate Cancer, Prostate Cancer
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: Male

Age: 18+

Code: NCT03541928

Phase2, Recruiting

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

for
Prostate Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: Male

Age: 18+

Code: NCT06099093

Recruiting

Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

for
Recurrent Prostate Cancer
Location: New York NY, Toronto
Sponsor: SpectraCure AB

Sex: Male

Age: 18+

Code: NCT03067051

Phase1, Phase2, Recruiting

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

for
Prostate Cancer
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: Male

Age: 0+

Code: NCT05882253

Recruiting

Early Prostate Cancer: Predicting Treatment Response

for
Prostate Cancer
Location: Irvine CA, Long Beach CA, Los Angeles CA,
Sponsor: University of California, Irvine

Sex: Male

Age: 18 - 70+

Code: NCT03770351

Recruiting

Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer

for
Breast Cancer, Prostate Cancer, Vertebral Metastasis, Pain
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 35 - 70+

Code: NCT00294151

Phase3, Recruiting

Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Durham NC, Ann Arbor MI, Madison WI, Los Angeles CA,
Sponsor: Syntrix Biosystems, Inc.

Sex: Male

Age: 18+

Code: NCT06228053

Phase2, Recruiting

A Study of Mental Health Care in People With Cancer

for
Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 65+

Code: NCT06037954

Recruiting

Comprehensive Assessment of Cancer Theranostic Response

for
Prostate Cancer
Location: New York NY, Houston TX
Sponsor: AIQ Solutions

Sex: Male

Age: 18+

Code: NCT06815354

Recruiting

18F-DCFPyL PET-CT Scan and Prostate Cancer

for
Prostate Cancer Adenocarcinoma
Location: Los Angeles CA
Sponsor: Lida Jafari

Sex: Male

Age: 18+

Code: NCT03852654

Phase2, Phase3, Recruiting

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

for
Androgen Axis Suppression, Prostatectomy, Prostate Cancer
Location: Boston MA, New York NY, Chicago IL, Kansas City KS,
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06274047

Phase3, Recruiting

A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer

for
Prostate Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Male

Age: 50+

Code: NCT06451445

Recruiting

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

for
Prostate Cancer, Lower Urinary Tract Symptoms
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT03802851

Recruiting

A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

for
Prostate Cancer
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male

Age: 18+

Code: NCT06347705

Phase2, Recruiting

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

for
Advanced Prostate Cancer, Metastatic Prostate Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: Male

Age: 18+

Code: NCT06062745

Phase1, Recruiting